LIXTE to allocate up to 25% of treasury to crypto

Nasdaq-listed LIXTE Biotechnology announced its board approved investing up to 25% of corporate cash in cryptocurrencies, including Bitcoin (BTC), according to Globe Newswire press release. The company said timing and size will depend on market conditions, and assets will be held with a regulated custodian in full compliance with financial, legal and audit requirements.